Pathogen Reduction |
Carrying pathogens (viruses, bacteria and parasites) [11, 16–18] |
Elimination of viruses and bacteria [19–22] |
Inhibiting growth of S. aureus via β-defensins and NETs induction [23–26] |
Growth inhibition of plasmodia via PF 4- and Duffy Ag-dependent manner [11] |
Platelet TLRs |
Pathogen detection [1] |
TLR4: LPS-induced platelet-neutrophil aggregation [35, 36], bacterial trapping via NETs in sepsis [13], possible role in thrombopoiesis [29] |
TLR2: producing ROS which may act directly on bacteria [39] |
Platelet CD40L (CD154) |
Inflammatory reactions via interaction with CD40 of endothelial cells: release of adhesion molecules [42] |
Secreting soluble CD40L, and promoting thrombosis [42] |
Binding of DCs: inhibiting DC differentiation, suppressing the proinflammatory cytokines |
IL-12p70 and TNF-α, promoting IL-10 secretion [47] |
Triggering of T cell responses and migration to inflammatory areas [48, 49] |
Promoting B cell differentiation and Ab class switching [50] |
Platelet MHC class I |
Interference with T cell-mediated cytotoxicity responses [53–55] |
Intracellular MHC class I connection with α granules [56] |
Platelet cytokines/chemokines |
Carrying abundant chemokines and cytokines involved in pro/anti-inflammatory pathways [57] |
PF4: promoting monocytes and neutrophils migration [62], inducing leukocyte pro-inflammatory cytokine release, phagocytosis, chemotaxis, generation of ROS [64] |
RANTES (CCL5): promoting monocytes and macrophages chemotaxis and recruitment to the endothelium [65–70] |
IL-1β: central to pro-inflammatory cytokine cascade [73], possible role in dengue virus replication in platelets [74, 75] |